ArticleBioanalysis2026
Biochemical characterization of cerebrospinal fluid in leptomeningeal carcinomatosis and infectious meningitis using the metabolic product model: a diagnostic performance evaluation in a single-center retrospective cohort.
Article in Bioanalysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical and CSF Measurements for Identification of Leptomeningeal Metastasis in Lung Adenocarcinoma.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLeptomeningeal metastasis (LM) and infectious meningitis often present with similar neurological symptoms, making clinical differentiation challenging. We retrospectively analyzed cerebrospinal fluid (CSF) biochemistry (lactate (LAC), lactate dehydrogenase (LDH), protein, glucose) in patients with confirmed LM and infectious meningitis (bacterial or viral) to delineate characteristic metabolic profiles. RESEARCH DESIGN AND
methodsIn this single-center retrospective cohort, we included 39 patients with cytology-confirmed LM, 38 with bacterial meningitis (BM), and 40 with viral meningitis (VM). We calculated an LDH × LAC product and compared its diagnostic performance to traditional biochemical markers using ROC analysis and DeLong tests for area under the curve differences.
resultsThe LDH×LAC index distinguished LM from VM and BM, outperforming the LDH/LAC ratio. Notably, 74.4% of LM patients had low CSF cell counts (≤50 × 10
conclusionsThese findings highlight that certain biochemical signatures can distinguish etiologies whereby high CSF lactate favors bacterial infection or aggressive tumor involvement, whereas normal glucose and low lactate favor viral causes. Our results emphasize distinct CSF signatures in neoplastic compared to infectious meningitis, suggesting metabolic profiling can aid diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.